US2561071A - Holder for subcutaneous administration of medicaments - Google Patents

Holder for subcutaneous administration of medicaments Download PDF

Info

Publication number
US2561071A
US2561071A US116963A US11696349A US2561071A US 2561071 A US2561071 A US 2561071A US 116963 A US116963 A US 116963A US 11696349 A US11696349 A US 11696349A US 2561071 A US2561071 A US 2561071A
Authority
US
United States
Prior art keywords
medicament
skin
cap
medicaments
holder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US116963A
Inventor
Prisk Howard Conley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US116963A priority Critical patent/US2561071A/en
Application granted granted Critical
Publication of US2561071A publication Critical patent/US2561071A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Definitions

  • This invention is concerned with an improved device for holding and applying liquid pharmaceutical or biological compounds in direct contact with the surface of the skin for subcutaneous absorption into the human system.
  • the medicament in liquid form is contained in a carrier device which through adhesive means is placed on the body with the liquid medicament contained therein in direct contact with the outer surface of the skin, the body of the carrier being sufficiently flexible to conform with the movements of the human body or that region of the latter to which the carrier is applied, the carrier further including a flexible cap which collapses under atmospheric pressure as the medicament is absorbed or otherwise penetrates into the systerm.
  • the device of the present invention acts as an instrument in a way comparable with that of the hyprodermic syringe, the difference being that whereas the hypodermic syringe pierces the skin and deposits a liquid directly into the body cavity, my device permits the liquid to enter said cavity slowly by absorption or direct penetration.
  • my improved device which enables the human system to absorb and utilize the medicament at all times in proper quantities, instead of applying, as in the case of a hypodermic syringe, an over dosage at one injection and allowing the injection to diminish as the body functions.
  • My device is also an improvement over administering medicines by the mouth, as its avoids deterioration and loss of the beneficial constituents of such medicines as a result of their attack by gastric juices and other bodily processes.
  • Fig. 1 is a vertical transverse sectional view taken through a medicine administering and holding device formed in accordance with the present invention; the device being shown in its complete form for holding in a sealed state therein biological or pharmaceutical solutions;
  • Fig. 2 is a similar view disclosing the device as it appears when applied to the surface of the skin;
  • Fig. 3 is a perspective view of the device.
  • my improved medicine holding and administering device comprises a capsule 0, formed to provide a base ring 5, which may be composed of a fabric such as crinoline or other fibrous material, woven or matted, to possess stifiness but with a sufiicient degree of flexibility so that it will conform to the movements of that part of the body to which it is applied.
  • the under surface, at least, of the ring 5 is coated with a pressure-sensitive adhesive, such as a rubber-base adhesive, by which the capsule is maintained in an applied position on the outer surface of the skin, and also to separably secure thereto a removable sealing strip 6, the latter being separated from the ring 5 immediately before the capsule device is applied to the skin.
  • a cap 8 mounteded on the ring 5 is the peripheral edge 1 of a cap 8.
  • This cap is formed preferably from a flexible liquid-resisting material, for example, a sheet of regenerated cellulose such as cellophane, or one of the chlorinated rubbers known commercially as Pliofilm or tensolite.
  • the cap 8 in association with the ring 5 and the sealing strip 6 provides a cavity within the capsule adapted for the reception of a medicament 9 in liquid form, the specific composition or uses of which being unimportant insofar as the present invention is concerned, except their ability to penetrate the human skin.
  • the base strip 6 is removed at the time of its application, so that the adhesive-bearing surfaces of the ring may be applied directly to the skin, as shown in Fig. 2.
  • the liquid body 9 comes into direct contact with the skin so that it may be absorbedrintothe system;
  • the cap 8 responds to atmospheric pressure and collapses, maintaining at all times close contact with the body of liquid vacua or sub-atmospheric pressures.
  • the rate of introduction of a and A precluding the formation within the capsule of' of the user of the device and a physician is assured that a patient is receiving a given medicament in" proper quantities.
  • The. device -;eliminates the-necessity for cleaning and sterilizing hypodermic needles and overcomes one-of the difii'culitiesor'particular objectionsso frequently encountered in the self -administering of various medical compounds.
  • the medicament contained in the cap portion ofthe -applicator is preferably admixed. or dissolved in a compound such-as propylene glycol,
  • anelectrolyte or catalyst may consist of" dilute hydrochloric acid in various: con.- centrations:-
  • Other compoundssuitable for effecting such .dialysiss may include magnesium sulphate or sodium. chloride;
  • the, accompanying' article or container of the present invention isapplied to a. thin part of the human skin, as in regions adjacent to body joints, as the shoulder, elbow or thelikep Various changes may be; made in my device without departing from the: spirit; and scope of.
  • the invention as the same has been defined in the the; upper surface of'said base member to overliethe'openin'g therein, said cap providing a cavity for the reception of a medicament, an adhesive applied to the under surface of said-base'member, and a removablesealing strip normally attached tothe-base member-by said adhesive and confining; said medicament within-the cavity of said 4 cap, said strip being removable from its sealing association with said base member to open the bottom of said cavity and the opening in said base member, whereby to enable the medicament contained within the cap to contact directly a selected region of the skin around which the device is positioned, the flexibility of the cap being such as to enable the same to flex inwardly to maintain closecontact thereof with the medicament as the volume of the latter progressively decreases in said cavity through absorption in the skin tissue.
  • Medicament holding and applying means comprising: a casing embodying a base and a fiexiblewalled cap, the latter forming a cavity for the reception of a medicament, and a removable sealing strip: normally. attached to the base, said strip beingremovable from its sealing association with said base to open the bottom of said cavity, thereby enabling the medicament contained within the cap to contact'directly a sealing region of the-skin around which the device is positioned;
  • humannbody for subdermali absorption comprise;
  • a base strip havingan under sidecoated with an adhesive, said stripubeingv formed intermedi. atelyL- thereof with i an opening; .a flexible walled.
  • inwardly 'tor maintainclosepressure contact with the-,medicament as; the volume ofthe latter progressively decreases in said- 'ca vity through absorptionin the skin tissue. and upon the presence; of anyatmospheric pressure differential on the inner and outer surfaces of the cavity.

Description

July 17, 1951 H. c. PRISK 2,561,071
HOLDER FOR SUBCUTANEOUS ADMINISTRATION OF MEDICAMENTS Filed Sept. 21, 1949 I 3mm 15! Pris/6 (Etern y Patented July 17, 1951 HOLDER FOR SUBCUTANEOUS ADMINIS- TRATION OF MEDICAMENTS Howard Conley Prisk, Westerville, Ohio Application September 21, 1949, Serial No. 116,963
3 Claims. 1
This invention is concerned with an improved device for holding and applying liquid pharmaceutical or biological compounds in direct contact with the surface of the skin for subcutaneous absorption into the human system.
It is common medical practice to introduce intravenously various preparations or medicaments, such as insulin, hormones, penicillin and.
many other preparations, including steroidal hormones, anti-biotics and the like, into the human system. Usually this operation requires the services of a physician, a graduate nurse or other similarly skilled technician, although self-administration is feasible and often practiced, as in the case of patients affected with diabetes. The use of hypodermic syringes in effecting such injections is disagreeable to many patients, even when handled by a skilled operator. The other alternative is the oral administration of preparations admitting of introduction into the alimentary tract. This method, however, is not altogeher satisfactory, in that certain preparations are destroyed, or their value substantially diminished, during passage through the alimentary tract. Also, this method is objectionable to many physicians in that dependence must be placed on the patient to self-administer medicines in the required quantities at definite intervals of time.
In accordance with the present invention, a
medicament in liquid form is contained in a carrier device which through adhesive means is placed on the body with the liquid medicament contained therein in direct contact with the outer surface of the skin, the body of the carrier being sufficiently flexible to conform with the movements of the human body or that region of the latter to which the carrier is applied, the carrier further including a flexible cap which collapses under atmospheric pressure as the medicament is absorbed or otherwise penetrates into the systerm.
I am aware that many patents have been granted on devices employed as surgical dressings or adhesive bandages, or in applying various medicaments to locally affected area such as wounds, cuts, burns, lacerations, etc. My present device is not concerned with the treatment of such localized afliictions, but is intended for introducing liquid pharmaceutical preparations into the blood stream through the skin. In other words, the device of the present invention acts as an instrument in a way comparable with that of the hyprodermic syringe, the difference being that whereas the hypodermic syringe pierces the skin and deposits a liquid directly into the body cavity, my device permits the liquid to enter said cavity slowly by absorption or direct penetration. In this way, a slow measured introduction of the medicament takes place with my improved device, which enables the human system to absorb and utilize the medicament at all times in proper quantities, instead of applying, as in the case of a hypodermic syringe, an over dosage at one injection and allowing the injection to diminish as the body functions. My device is also an improvement over administering medicines by the mouth, as its avoids deterioration and loss of the beneficial constituents of such medicines as a result of their attack by gastric juices and other bodily processes.
For a further understanding of the invention, reference is to be had to the following description and the accompanying drawing, wherein:
Fig. 1 is a vertical transverse sectional view taken through a medicine administering and holding device formed in accordance with the present invention; the device being shown in its complete form for holding in a sealed state therein biological or pharmaceutical solutions;
Fig. 2 is a similar view disclosing the device as it appears when applied to the surface of the skin;
Fig. 3 is a perspective view of the device.
Referring to the drawings, my improved medicine holding and administering device comprises a capsule 0, formed to provide a base ring 5, which may be composed of a fabric such as crinoline or other fibrous material, woven or matted, to possess stifiness but with a sufiicient degree of flexibility so that it will conform to the movements of that part of the body to which it is applied. The under surface, at least, of the ring 5 is coated with a pressure-sensitive adhesive, such as a rubber-base adhesive, by which the capsule is maintained in an applied position on the outer surface of the skin, and also to separably secure thereto a removable sealing strip 6, the latter being separated from the ring 5 immediately before the capsule device is applied to the skin.
Mounted on the ring 5 is the peripheral edge 1 of a cap 8. This cap is formed preferably from a flexible liquid-resisting material, for example, a sheet of regenerated cellulose such as cellophane, or one of the chlorinated rubbers known commercially as Pliofilm or tensolite. The cap 8 in association with the ring 5 and the sealing strip 6 provides a cavity within the capsule adapted for the reception of a medicament 9 in liquid form, the specific composition or uses of which being unimportant insofar as the present invention is concerned, except their ability to penetrate the human skin.
In the use of my improved capsule device, the base strip 6 is removed at the time of its application, so that the adhesive-bearing surfaces of the ring may be applied directly to the skin, as shown in Fig. 2. In this way, the liquid body 9 comes into direct contact with the skin so that it may be absorbedrintothe system; As the liquid body is absorbed, the cap 8 responds to atmospheric pressure and collapses, maintaining at all times close contact with the body of liquid vacua or sub-atmospheric pressures.
Thus with the use of the caps le,forming.the.
present invention, the rate of introduction of a and A precluding the formation within the capsule of' of the user of the device and a physician is assured that a patient is receiving a given medicament in" proper quantities. The. device -;eliminates the-necessity for cleaning and sterilizing hypodermic needles and overcomes one-of the difii'culitiesor'particular objectionsso frequently encountered in the self -administering of various medical compounds. 1 I
The medicament contained in the cap portion ofthe -applicator is preferably admixed. or dissolved in a compound such-as propylene glycol,
ethylene glycol, alcohol or a saline solution. Alsov there may be maintained in the solution-an electrolyte or catalyst which renders. the. region. or
skinuor membrane towhich the device is applied morereadilyprmeable-to the passage 'of the liq-. uid medicaments through dilation. ofs-dermal pas-- sages. Such anelectrolyte or catalyst may consist of" dilute hydrochloric acid in various: con.- centrations:- Other compoundssuitable for effecting such .dialysiss may include magnesium sulphate or sodium. chloride; Preferably, the, accompanying' article or container of the present inventionisapplied to a. thin part of the human skin, as in regions adjacent to body joints, as the shoulder, elbow or thelikep Various changes may be; made in my device without departing from the: spirit; and scope of.
the invention as the same has been defined in the the; upper surface of'said base member to overliethe'openin'g therein, said cap providing a cavity for the reception of a medicament, an adhesive applied to the under surface of said-base'member, and a removablesealing strip normally attached tothe-base member-by said adhesive and confining; said medicament within-the cavity of said 4 cap, said strip being removable from its sealing association with said base member to open the bottom of said cavity and the opening in said base member, whereby to enable the medicament contained within the cap to contact directly a selected region of the skin around which the device is positioned, the flexibility of the cap being such as to enable the same to flex inwardly to maintain closecontact thereof with the medicament as the volume of the latter progressively decreases in said cavity through absorption in the skin tissue.
2. Medicament holding and applying means comprising: a casing embodying a base and a fiexiblewalled cap, the latter forming a cavity for the reception of a medicament, and a removable sealing strip: normally. attached to the base, said strip beingremovable from its sealing association with said base to open the bottom of said cavity, thereby enabling the medicament contained within the cap to contact'directly a sealing region of the-skin around which the device is positioned;
the fiexibility of-the c'ap'bein'g such as to enable the walls thereof to flex: inwardly and: maintain.
close contact with the medicament as the supply.
humannbody for subdermali absorption comprise;
ing: :a base strip havingan under sidecoated with an adhesive, said stripubeingv formed intermedi. atelyL- thereof with i an opening; .a flexible walled.
cap .securedtonthe uppermsurfacepofi said basestrip toioverlie the-opening therein, said cap pro.- viding acavity forthe reception of-the medicarment, and a removable (sealing strip normally atrta-ched toxthe base member by: said adhesiveand, confining said medicamentwithin said cap, said strip being removable from; its adhesive: ass0cia--; ti0n;;with-. said'base-strip' to enable the medicament'containedwithinthecap to contact directly a selected region, of? the .skin, around which the deviceis positioned, theflexibility ofthematerial forming .thecap being such; 'asto enablesame toflex? inwardly 'tor maintainclosepressure contact with the-,medicament as; the volume ofthe latter progressively decreases in said- 'ca vity through absorptionin the skin tissue. and upon the presence; of anyatmospheric pressure differential on the inner and outer surfaces of the cavity.
HOWARD-CONLEY PRISK.
REFERENCES. CITED The following references are of record in the file of this patent:
UNITED STATES PATENTS Number Name- Date 720,812 Johnson Feb. 17, 1903; 2,443,140
Larsen June 8, 1943-
US116963A 1949-09-21 1949-09-21 Holder for subcutaneous administration of medicaments Expired - Lifetime US2561071A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US116963A US2561071A (en) 1949-09-21 1949-09-21 Holder for subcutaneous administration of medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US116963A US2561071A (en) 1949-09-21 1949-09-21 Holder for subcutaneous administration of medicaments

Publications (1)

Publication Number Publication Date
US2561071A true US2561071A (en) 1951-07-17

Family

ID=22370283

Family Applications (1)

Application Number Title Priority Date Filing Date
US116963A Expired - Lifetime US2561071A (en) 1949-09-21 1949-09-21 Holder for subcutaneous administration of medicaments

Country Status (1)

Country Link
US (1) US2561071A (en)

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2817335A (en) * 1955-06-10 1957-12-24 Thalmer J Thompson Bandage and dressing
US3053255A (en) * 1957-12-19 1962-09-11 Meyer Friedrich Process of percutaneously administering exact doses of physiologically active agents and composite unit therefor
US3651932A (en) * 1969-10-09 1972-03-28 Zahn Porzellan Kge Muhbauer & Duplex capsule for dental filling material
US3837340A (en) * 1971-10-20 1974-09-24 Lilly Co Eli Device for administering immunication against virus
US4127339A (en) * 1976-10-19 1978-11-28 Malacheski Joseph J Dispenser package for fluent material
US4232671A (en) * 1978-06-23 1980-11-11 Crump Charles L Safety eyewash package and container therefor
US4341208A (en) * 1980-07-14 1982-07-27 Whitman Medical Corporation Moisture-retentive covering for ointment application
FR2534140A1 (en) * 1982-10-12 1984-04-13 Fournier Laboratoires NEW DEVICE FOR PERCUTANEOUS ADMINISTRATION OF MEDICINES
EP0123539A2 (en) * 1983-04-21 1984-10-31 James Chester Breneman Immune responses to ingestible substances
US4585452A (en) * 1983-04-12 1986-04-29 Key Pharmaceuticals, Inc. Transdermal systemic dosage forms
US4619652A (en) * 1982-12-23 1986-10-28 Alza Corporation Dosage form for use in a body mounted pump
US4649075A (en) * 1984-08-09 1987-03-10 Leonora Jost Transdermal and transmucosal vortexed foam devices and the method of making
US4655766A (en) * 1985-08-01 1987-04-07 Alza Corporation Fluid imbibing pump with self-regulating skin patch
US4687481A (en) * 1984-10-01 1987-08-18 Biotek, Inc. Transdermal drug delivery system
US4710191A (en) * 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US4812305A (en) * 1987-11-09 1989-03-14 Vocal Rodolfo S Well medicine strip
US4822617A (en) * 1983-01-18 1989-04-18 Elan Corporation P.L.C. Drug delivery device
US4877618A (en) * 1988-03-18 1989-10-31 Reed Jr Fred D Transdermal drug delivery device
US4904475A (en) * 1985-05-03 1990-02-27 Alza Corporation Transdermal delivery of drugs from an aqueous reservoir
US4917688A (en) * 1987-01-14 1990-04-17 Nelson Research & Development Co. Bandage for transdermal delivery of systemically-active drug
US5139023A (en) * 1989-06-02 1992-08-18 Theratech Inc. Apparatus and method for noninvasive blood glucose monitoring
US5498417A (en) * 1994-05-12 1996-03-12 Coating Sciences, Inc. Transdermal delivery of appetite suppressant drug
US5962011A (en) * 1993-12-06 1999-10-05 Schering-Plough Healthcare Products, Inc. Device for delivery of dermatological ingredients
US20030152528A1 (en) * 2001-05-01 2003-08-14 Parminder Singh Hydrogel compositions for tooth whitening
US20030170308A1 (en) * 2001-05-01 2003-09-11 Cleary Gary W. Hydrogel compositions
US6676961B1 (en) 2002-03-06 2004-01-13 Automated Carrier Technologies, Inc. Transdermal patch assembly
US20040105834A1 (en) * 2001-05-01 2004-06-03 Corium International Hydrogel compositions with an erodible backing member
US20040166147A1 (en) * 2002-12-13 2004-08-26 Schering-Plough Healthcare Products, Inc. Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
US20110118646A1 (en) * 2003-07-03 2011-05-19 Corium International, Inc. Wound dressing, ingredient delivery service and iv hold-down, and method relating to same
US8273405B2 (en) 2001-05-01 2012-09-25 A.V. Topcheiv Institute of Petrochemical Synthesis, Russian Academy of Sciences Water-absorbent adhesive compositions and associated methods of manufacture and use
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8658201B2 (en) 2004-01-30 2014-02-25 Corium International, Inc. Rapidly dissolving film for delivery of an active agent
US8753669B2 (en) 2001-05-01 2014-06-17 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences Two-phase, water-absorbent bioadhesive composition
US8784879B2 (en) 2009-01-14 2014-07-22 Corium International, Inc. Transdermal administration of tamsulosin
US8821901B2 (en) 2001-05-01 2014-09-02 A.V. Topchiev Institute Of Petrochemical Synthesis Russian Academy Of Sciences Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US9242021B2 (en) 2004-08-05 2016-01-26 Corium International, Inc. Adhesive composition
USD859533S1 (en) * 2017-10-03 2019-09-10 Nsi International, Inc. Rupturable toy
US20210016070A1 (en) * 2018-03-30 2021-01-21 Labnpeople Co., Ltd. Multi-type microneedle
USD934067S1 (en) * 2018-08-23 2021-10-26 Sargento Foods Inc. Food package

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US720812A (en) * 1901-01-12 1903-02-17 Robert W Johnson Vaccination-shield.
US2443140A (en) * 1946-04-11 1948-06-08 Robert E Larsen Boil cup

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US720812A (en) * 1901-01-12 1903-02-17 Robert W Johnson Vaccination-shield.
US2443140A (en) * 1946-04-11 1948-06-08 Robert E Larsen Boil cup

Cited By (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2817335A (en) * 1955-06-10 1957-12-24 Thalmer J Thompson Bandage and dressing
US3053255A (en) * 1957-12-19 1962-09-11 Meyer Friedrich Process of percutaneously administering exact doses of physiologically active agents and composite unit therefor
US3651932A (en) * 1969-10-09 1972-03-28 Zahn Porzellan Kge Muhbauer & Duplex capsule for dental filling material
US3837340A (en) * 1971-10-20 1974-09-24 Lilly Co Eli Device for administering immunication against virus
US4127339A (en) * 1976-10-19 1978-11-28 Malacheski Joseph J Dispenser package for fluent material
US4232671A (en) * 1978-06-23 1980-11-11 Crump Charles L Safety eyewash package and container therefor
US4341208A (en) * 1980-07-14 1982-07-27 Whitman Medical Corporation Moisture-retentive covering for ointment application
FR2534140A1 (en) * 1982-10-12 1984-04-13 Fournier Laboratoires NEW DEVICE FOR PERCUTANEOUS ADMINISTRATION OF MEDICINES
EP0107575A1 (en) * 1982-10-12 1984-05-02 Laboratoires Fournier S.A. Percutaneous administration device of the active principle
US4619652A (en) * 1982-12-23 1986-10-28 Alza Corporation Dosage form for use in a body mounted pump
US4822617A (en) * 1983-01-18 1989-04-18 Elan Corporation P.L.C. Drug delivery device
US4585452A (en) * 1983-04-12 1986-04-29 Key Pharmaceuticals, Inc. Transdermal systemic dosage forms
EP0123539A2 (en) * 1983-04-21 1984-10-31 James Chester Breneman Immune responses to ingestible substances
EP0123539A3 (en) * 1983-04-21 1987-09-09 James Chester Breneman Immune responses to ingestible substances
US4649075A (en) * 1984-08-09 1987-03-10 Leonora Jost Transdermal and transmucosal vortexed foam devices and the method of making
US4687481A (en) * 1984-10-01 1987-08-18 Biotek, Inc. Transdermal drug delivery system
US4904475A (en) * 1985-05-03 1990-02-27 Alza Corporation Transdermal delivery of drugs from an aqueous reservoir
US4655766A (en) * 1985-08-01 1987-04-07 Alza Corporation Fluid imbibing pump with self-regulating skin patch
US4710191A (en) * 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments
US4917688A (en) * 1987-01-14 1990-04-17 Nelson Research & Development Co. Bandage for transdermal delivery of systemically-active drug
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US4812305A (en) * 1987-11-09 1989-03-14 Vocal Rodolfo S Well medicine strip
US4877618A (en) * 1988-03-18 1989-10-31 Reed Jr Fred D Transdermal drug delivery device
US5139023A (en) * 1989-06-02 1992-08-18 Theratech Inc. Apparatus and method for noninvasive blood glucose monitoring
US5291887A (en) * 1989-06-02 1994-03-08 Anesta Corporation Apparatus and methods for noninvasive blood substance monitoring
US5962011A (en) * 1993-12-06 1999-10-05 Schering-Plough Healthcare Products, Inc. Device for delivery of dermatological ingredients
US5498417A (en) * 1994-05-12 1996-03-12 Coating Sciences, Inc. Transdermal delivery of appetite suppressant drug
USRE45666E1 (en) 2000-07-07 2015-09-08 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US9084723B2 (en) 2001-05-01 2015-07-21 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions with an erodible backing member
US20030170308A1 (en) * 2001-05-01 2003-09-11 Cleary Gary W. Hydrogel compositions
US10869947B2 (en) 2001-05-01 2020-12-22 Corium, Inc. Hydrogel compositions
US10835454B2 (en) 2001-05-01 2020-11-17 Corium, Inc. Hydrogel compositions with an erodible backing member
US10179096B2 (en) 2001-05-01 2019-01-15 Corium International, Inc. Hydrogel compositions for tooth whitening
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8273405B2 (en) 2001-05-01 2012-09-25 A.V. Topcheiv Institute of Petrochemical Synthesis, Russian Academy of Sciences Water-absorbent adhesive compositions and associated methods of manufacture and use
US9687428B2 (en) 2001-05-01 2017-06-27 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US8481071B2 (en) 2001-05-01 2013-07-09 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8481059B2 (en) 2001-05-01 2013-07-09 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences Hydrogel compositions
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8617647B2 (en) 2001-05-01 2013-12-31 A.V. Topchiev Institutes of Petrochemical Synthesis, Russian Academy of Sciences Water-absorbent adhesive compositions and associated methods of manufacture and use
US9532935B2 (en) 2001-05-01 2017-01-03 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US8728445B2 (en) 2001-05-01 2014-05-20 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences Hydrogel Compositions
US8741331B2 (en) 2001-05-01 2014-06-03 A. V. Topchiev Institute of Petrochemicals Synthesis, Russian Academy of Sciences Hydrogel compositions with an erodible backing member
US8753669B2 (en) 2001-05-01 2014-06-17 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences Two-phase, water-absorbent bioadhesive composition
US9259504B2 (en) 2001-05-01 2016-02-16 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Non-electrically conductive hydrogel composition
US8821901B2 (en) 2001-05-01 2014-09-02 A.V. Topchiev Institute Of Petrochemical Synthesis Russian Academy Of Sciences Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20040105834A1 (en) * 2001-05-01 2004-06-03 Corium International Hydrogel compositions with an erodible backing member
US9089481B2 (en) 2001-05-01 2015-07-28 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions demonstrating phase separation on contact with aqueous media
US9127140B2 (en) 2001-05-01 2015-09-08 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Water-absorbent adhesive compositions and associated methods of manufacture and use
US20030152528A1 (en) * 2001-05-01 2003-08-14 Parminder Singh Hydrogel compositions for tooth whitening
US6676961B1 (en) 2002-03-06 2004-01-13 Automated Carrier Technologies, Inc. Transdermal patch assembly
US20040166147A1 (en) * 2002-12-13 2004-08-26 Schering-Plough Healthcare Products, Inc. Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
US7976867B2 (en) 2002-12-13 2011-07-12 Schering-Plough Healthcare Products Inc. Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
US20110118646A1 (en) * 2003-07-03 2011-05-19 Corium International, Inc. Wound dressing, ingredient delivery service and iv hold-down, and method relating to same
US9839560B2 (en) 2003-07-03 2017-12-12 Corium International, Inc. Wound dressing, ingredient delivery device and IV hold-down, and method relating to same
US8658201B2 (en) 2004-01-30 2014-02-25 Corium International, Inc. Rapidly dissolving film for delivery of an active agent
US9144552B2 (en) 2004-01-30 2015-09-29 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences Rapidly dissolving film for delivery of an active agent
US9242021B2 (en) 2004-08-05 2016-01-26 Corium International, Inc. Adhesive composition
US9610253B2 (en) 2009-01-14 2017-04-04 Corium International, Inc. Transdermal administration of tamsulosin
US10238612B2 (en) 2009-01-14 2019-03-26 Corium International, Inc. Transdermal administration of tamsulosin
US8784879B2 (en) 2009-01-14 2014-07-22 Corium International, Inc. Transdermal administration of tamsulosin
USD859533S1 (en) * 2017-10-03 2019-09-10 Nsi International, Inc. Rupturable toy
US20210016070A1 (en) * 2018-03-30 2021-01-21 Labnpeople Co., Ltd. Multi-type microneedle
USD934067S1 (en) * 2018-08-23 2021-10-26 Sargento Foods Inc. Food package

Similar Documents

Publication Publication Date Title
US2561071A (en) Holder for subcutaneous administration of medicaments
US4233973A (en) Apparatus for administering intravenous drugs
US5147329A (en) Intravenous access devices
US3977401A (en) Injection apparatus
US4998921A (en) Intermittent I.V. therapy needle sheath
US6502699B1 (en) Method and kit for making injections and withdrawing blood without the use of protective gloves
EP0264367A1 (en) Medical syringe
Hong et al. Menghini needle biopsy of the liver
WO2009031144A1 (en) Envelope containing sterile needle
US5098404A (en) Hypodermic syringe receptacle
O'brien Acute and chronic osteomyelitis
JPH02232047A (en) Germ-free adhesive foil for medical preparation
CN211327434U (en) Remaining needle film with anti-inflammatory effect
Gritsch et al. Value of indwelling catheters in intravenous therapy: Description of new needle and catheter set
US3219037A (en) Finger-tip applicator
ATE292989T1 (en) MEDICAL DEVICE HAVING A RETRACTABLE NEEDLE
TW201912193A (en) Medicament delivery device comprising a wipe assembly
Lewis Disappearing plastic cannula
JPH0131908B2 (en)
CZ31409U1 (en) An injection device
CN217187468U (en) Implanted local drug delivery device
Buchbinder Use of penicillin as a root canal treatment
RU2003352C1 (en) Medical needle
CN208809065U (en) The non-disposable washing pipe type infusion bag of PVC
JPH067722Y2 (en) Continuous drug infusion device with bellows container